首页> 外文OA文献 >The need and benefits of established radiopharmacy in developing African countries
【2h】

The need and benefits of established radiopharmacy in developing African countries

机译:在发展中的非洲国家建立放射性药物的必要性和益处

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our work is to present the current status, and in the same time the need and benefit of establishment of Radiopharmacy practice in Eastern Africa using the perspective of Kenya and Ethiopia. The exact information on the status and size of Radiopharmacy units, regionally, is still not clearly documented, as well human resources, education, suitable training and local demand for the Radiopharmacy and Nuclear Medicine services. The Radiopharmacy Practice requires well-defined and controlled conditions to avoid the risk contamination with microbes, pyrogens and particulate matter as well as cross contamination with other radiopharmaceuticals. Corresponding to the expected improvement, the principles of Good Practices in all levels should be planned, introduced by the planned priority and strictly observed in the production, preparation, testing and the packaging of the final product ready for use. Because non-communicable diseases (NCDs) are a challenge of epidemic proportion and that they will be the commonest cause of mortality in Africa by 2030, early detection and treatment can significantly improve patient outcomes. Radiopharmaceuticals should have become of invaluable benefit because they offer the most sensitive tools in the detection, diagnosis and targeted therapy of NCDs and also infectious diseases. In light of the foregoing, therefore, radiopharmacy has a huge role to play in responding to the unfolding new disease trends in sub-Saharan Africa. The preparation of radiopharmaceuticals for human use requires that it is carried out in well-defined and controlled conditions to avoid the risk contamination with microbes, pyrogens and particulate matter as well as cross contamination with other radiopharmaceuticals. Every procedure undertaken should be done according to the clearly defined protocol and under the right conditions so as to build quality into the product. Radiopharmacy professionals should have adequate training in all aspects of sterile production, quality control, GMP, GLP, radiation safety and radiochemistry to ensure that they are competent to handle radioactive materials and that they can take responsibility for their level of practice.
机译:我们的工作是从肯尼亚和埃塞俄比亚的角度介绍目前的状况,同时提出在东部非洲建立放射药学实践的需要和利益。仍然没有清楚地记录有关地区放射性药物单位的状况和规模的确切信息,以及人力资源,教育,适当的培训以及当地对放射性药物和核医学服务的需求。放射性药物实践要求有明确定义和可控制的条件,以避免微生物,热原和颗粒物污染风险以及与其他放射性药物交叉污染。与预期的改进相对应,应计划各个级别的“良好实践”原则,并按计划的优先顺序进行介绍,并在准备使用的最终产品的生产,制备,测试和包装中严格遵守。由于非传染性疾病(NCDs)是流行病的挑战,并且到2030年它们将成为非洲最常见的死亡原因,因此早期发现和治疗可以显着改善患者的预后。放射性药物本应成为无价之宝,因为它们在非传染性疾病以及传染病的检测,诊断和靶向治疗中提供了最灵敏的工具。因此,鉴于上述情况,放射性药物在应对撒哈拉以南非洲不断发展的新疾病趋势中可发挥巨大作用。供人类使用的放射性药物的制备要求在定义明确且可控制的条件下进行,以避免微生物,热原和颗粒物污染风险以及与其他放射性药物的交叉污染。应当按照明确定义的规程并在正确的条件下执行所执行的每个程序,以便将质量纳入产品中。放射药学专业人士应在无菌生产,质量控制,GMP,GLP,放射安全和放射化学的各个方面接受充分的培训,以确保他们有能力处理放射性物质,并对自己的实践水平负责。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号